Insider · CIK 0001709989
Joseph Fralin Woody
Files at AVNS (AVANOS MEDICAL, INC.), RCEL (AVITA Medical, Inc.). First filing Jun 3, 2026, latest Jun 10, 2026.
In brief
Joseph Fralin Woody files SEC Form 4 as director and CEO at RCEL (AVITA Medical, Inc.), and also at AVNS (AVANOS MEDICAL, INC.). Since Jun 3, 2026, Joseph Fralin Woody has reported 4 open-market buys worth $189k and 0 open-market sells worth $0, the latest filed on Jun 10, 2026.
A track record needs three past buys with six months of prices behind them; Joseph Fralin Woody has 0, so none is measured yet.
The newest scored trade: bought $21k of RCEL on Jun 9, 2026, filed Jun 10, 2026, scored 39 (weak). In the last 12 months: 4 buys worth $189k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RCEL: AVITA Medical, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | AVITA Medical, Inc. | $21k 5,200 shares | +5% | +26% from low-39% from high | |
| 45Moderate | AVITA Medical, Inc. | $42k 10,000 shares | +11% | +26% from low-39% from high | |
| 45Moderate | AVITA Medical, Inc. | $41k 10,000 shares | +12% | +27% from low-38% from high | |
| 48Moderate | AVITA Medical, Inc. | $85k 20,000 shares | - | +34% from low-35% from high |
Transactions
Every row this insider has filed, 24 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +5,200 | $4.00 | $21k | 107,961 | Jun 10, 2026 |
| Jun 9, 2026 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +5,000 | $4.20 | $21k | 97,761 | Jun 9, 2026 |
| Jun 9, 2026 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +5,000 | $4.18 | $21k | 102,761 | Jun 9, 2026 |
| Jun 3, 2026 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +5,000 | $4.10 | $20k | 87,761 | Jun 5, 2026 |
| Jun 3, 2026 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +5,000 | $4.09 | $20k | 92,761 | Jun 5, 2026 |
| Jan 5, 2026 | RCEL AVITA Medical, Inc. | AGrant or award Common Stock | +40,547 | - | - | 60,547 | Jun 4, 2026 |
| Jan 20, 2026 | RCEL AVITA Medical, Inc. | AGrant or award Common Stock | +22,214 | - | - | 82,761 | Jun 4, 2026 |
| Jan 5, 2026 | RCEL AVITA Medical, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +29,446 | $0.00 | $0 | 29,446 | Jun 4, 2026 |
| Jan 20, 2026 | RCEL AVITA Medical, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +16,133 | $0.00 | $0 | 16,133 | Jun 4, 2026 |
| Jun 1, 2026 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +5,000 | $4.34 | $22k | 5,000 | Jun 3, 2026 |
| Jun 1, 2026 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +5,000 | $4.26 | $21k | 10,000 | Jun 3, 2026 |
| Jun 2, 2026 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +5,000 | $4.18 | $21k | 15,000 | Jun 3, 2026 |
| Jun 2, 2026 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +5,000 | $4.21 | $21k | 20,000 | Jun 3, 2026 |
| Mar 6, 2025 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -11,827 | $15.30 | $181k | 423,025 | Mar 10, 2025 |
| Mar 6, 2025 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -20,249 | $15.30 | $310k | 402,776 | Mar 10, 2025 |
| Mar 4, 2025 | AVNS AVANOS MEDICAL, INC. | MOption exercise Common Stock | +32,158 | $0.00 | $0 | 453,203 | Mar 6, 2025 |
| Mar 4, 2025 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -10,167 | $15.13 | $154k | 443,036 | Mar 6, 2025 |
| Mar 4, 2025 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -8,184 | $15.13 | $124k | 434,852 | Mar 6, 2025 |
| Mar 18, 2024 | AVNS AVANOS MEDICAL, INC. | MOption exercise Common Stock | +15,821 | $0.00 | $0 | 453,810 | Mar 19, 2024 |
| Mar 18, 2024 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -7,095 | $19.09 | $135k | 446,715 | Mar 19, 2024 |
| Mar 18, 2024 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -26,670 | $19.09 | $509k | 420,045 | Mar 19, 2024 |
| Mar 6, 2024 | AVNS AVANOS MEDICAL, INC. | AGrant or award Common Stock | +137,147 | $19.14 | $2.6M | 446,857 | Mar 7, 2024 |
| Mar 6, 2024 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -8,868 | $19.00 | $168k | 437,989 | Mar 7, 2024 |
| Mar 5, 2024 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -8,431 | $18.76 | $158k | 308,788 | Mar 6, 2024 |
Questions about Joseph Fralin Woody
Answered from the filings on this page, as of the latest one.
Is Joseph Fralin Woody buying or selling?
In the last 12 months Joseph Fralin Woody reported 4 open-market buys worth $189k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $21k of RCEL on Jun 9, 2026. Grants, option exercises and tax withholding are not counted.
How did Joseph Fralin Woody's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joseph Fralin Woody has 0.
Where does Joseph Fralin Woody file Form 4?
Joseph Fralin Woody has filed Form 4 at RCEL (AVITA Medical, Inc.); AVNS (AVANOS MEDICAL, INC.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.